Patents by Inventor Annamaria Soliani Raschini

Annamaria Soliani Raschini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stable pharmaceutical formulation comprising a reconstituted pulmonary surfactant composition
    Patent number: 10543256
    Abstract: Physically and chemically stable pharmaceutical formulations in the form of an aqueous suspension comprising a reconstituted pulmonary surfactant are useful for the prophylaxis and/or treatment of respiratory distress syndrome (RDS) and other respiratory disorders.
    Type: Grant
    Filed: August 23, 2017
    Date of Patent: January 28, 2020
    Assignee: CHIESI FARMACEUTICI S.P.A.
    Inventors: Franco Sartor, Marisa Pertile, Annamaria Soliani Raschini
  • STABLE PHARMACEUTICAL FORMULATION COMPRISING A RECONSTITUTED PULMONARY SURFACTANT COMPOSITION
    Publication number: 20180055914
    Abstract: Physically and chemically stable pharmaceutical formulations in the form of an aqueous suspension comprising a reconstituted pulmonary surfactant are useful for the prophylaxis and/or treatment of respiratory distress syndrome (RDS) and other respiratory disorders.
    Type: Application
    Filed: August 23, 2017
    Publication date: March 1, 2018
    Applicant: CHIESI FARMACEUTICI S.P.A.
    Inventors: Franco Sartor, Marisa Pertile, Annamaria Soliani Raschini
  • Melatonin-based formulations for parenteral administration
    Patent number: 9468626
    Abstract: Pharmaceutical formulations comprising nanoparticles of melatonin are useful for the treatment of neonatal brain injury.
    Type: Grant
    Filed: March 10, 2015
    Date of Patent: October 18, 2016
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Annamaria Soliani Raschini, Akif Emre Türeli, Eva Marie Prinz
  • MELATONIN-BASED FORMULATIONS FOR PARENTERAL ADMINISTRATION
    Publication number: 20150258064
    Abstract: Pharmaceutical formulations comprising nanoparticles of melatonin are useful for the treatment of neonatal brain injury.
    Type: Application
    Filed: March 10, 2015
    Publication date: September 17, 2015
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Annamaria Soliani RASCHINI, Akif Emre TÜRELI, Eva Marie PRINZ
  • Reconstituted surfactant composition containing analogs of surfactant protein B (SP-B) and surfactant protein C (SP-C)
    Patent number: 8399406
    Abstract: Reconstituted pulmonary surfactants comprising a lipid carrier, a combination of polypeptide analog of the native surfactant protein SP-C with a particular polypeptide analog of the native surfactant protein SP-B may be used for the treatment or prophylaxis of RDS and other respiratory disorders.
    Type: Grant
    Filed: May 27, 2010
    Date of Patent: March 19, 2013
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Fausto Pivetti, Monica Bocchi, Annamaria Soliani Raschini
  • LIQUID PROPELLANT-FREE FORMULATION COMPRISING AN ANTIMUSCARINIC DRUG
    Publication number: 20120220557
    Abstract: Liquid, propellant-free pharmaceutical formulation for administration by nebulization which comprising an antimuscarinic drug as active ingredient are useful for the prevention and/or treatment of a wide range of conditions including respiratory disorders.
    Type: Application
    Filed: February 10, 2012
    Publication date: August 30, 2012
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Annamaria Soliani RASCHINI, Emilio Lutero
  • RECONSTITUTED SURFACTANT COMPOSITION CONTAINING ANALOGS OF SURFACTANT PROTEIN B (SP-B) AND SURFACTANT PROTEIN C (SP-C)
    Publication number: 20110003733
    Abstract: Reconstituted pulmonary surfactants comprising a lipid carrier, a combination of polypeptide analog of the native surfactant protein SP-C with a particular polypeptide analog of the native surfactant protein SP-B may be used for the treatment or prophylaxis of RDS and other respiratory disorders.
    Type: Application
    Filed: May 27, 2010
    Publication date: January 6, 2011
    Applicant: CHIESI FARMACEUTICI S.P.A.
    Inventors: FAUSTO PIVETTI, MONICA BOCCHI, ANNAMARIA SOLIANI RASCHINI
  • Pharmaceutical formulations comprising a long-acting beta2-agonist for administration by nebulisation
    Publication number: 20070065366
    Abstract: The invention relates to a liquid, propellant-free pharmaceutical formulation in the form of ready-to-use preparation for administration by nebulisation comprising a water soluble salt of the beta2-agonist 8-hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone as active ingredient. The active ingredient is chemically stable in the formulation, and said formulation is provided of an adequate shelf-life suitable for commercial distribution, storage and use.
    Type: Application
    Filed: July 28, 2006
    Publication date: March 22, 2007
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Annamaria Soliani Raschini, Alessandro Bodria